Browse

S-Space

Browsing by Author Heo, Dae Seog

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 60 of 244

Issue Date Title / Author(s) / CitationFileAltmetrics
1982-06
혈액투석을 이용한 메타놀 중독환자 치료일례

허대석; 오하영; 김성권; 이정상

Seoul J Med, Vol.23 No.2, pp. 279-283

view file
1994
Multiple myeloma presenting as a testicular mass.

Kang, Min Jong; Kim, Tae You; Bang, Yung-Jue; Heo, Dae Seog; Park, Seonyang; Kim, Byoung Kook; Kim, Noe Kyoung; Kim, Chul Woo

The Korean Journal of Internal Medicine, Vol.9 No.1, pp.39-42

DOI
1996
Prognostic factors of patients with thymoma.
DOI
1998-01
Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II)
DOI
1998-09
Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/β2-microglobulin gene in patients with cancer
DOI
1999-11
Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma

Hong, Semie; Wu, Hong Gyun; Chie, Eui Kyu; Bang, Yung-Jue; Heo, Dae Seog; Kim, Kwang Hyun; Sung, Myung Whun; Park, Charn Il

International Journal of Radiation Oncology Biology Physics, Vol.45 No.4, pp.901-905

DOI
2000-12
Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma: Results of a randomized controlled trial
DOI
2001-04
A phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies
DOI
2001-07
Prognostic factors of Krukenberg's tumor

Kim, Hark K.; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong

Gynecologic Oncology, Vol.82 No.1, pp.105-109

DOI
2002
Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme
link
2002-05
Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: A case-control study
DOI
2002-06
A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer
DOI
2002-07
Docetaxel 75 mg/m2 is active and well tolerated in patients with metastatic or recurrent gastric cancer: A phase II trial
DOI
2002-07
Colorectal cancer in Korea: characteristics and trends

Kim, Dong-Wan; Bang, Yung-Jue; Heo, Dae Seog; Kim, Noe Kyeong

Tumori, Vol.88 No.4, pp.262-265

DOI
2002-09
Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial
link
2002-10
Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer

Kim, Suzy; Kim, Sun Whe; Bang, Yung-Jue; Heo, Dae Seog; Ha, Sung Whan

International Journal of Radiation Oncology Biology Physics, Vol.54 No.2, pp.414-419

DOI
2002-12
Chylothorax in Gorham's disease
DOI
2003-01
Induction chemotherapy followed by radiotherapy in the treatment of anal cancer
DOI
2003-01
Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer
DOI
2003-11
Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy - Result of chemotherapy in NK/T-cell lymphoma
DOI
2003-12
Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients - Comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage
DOI
2003-12
Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: Methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone
DOI
2004-05
Discrepancies among patients, family members, and physicians in Korea in terms of values regarding the withholding of treatment from patients with terminal malignancies
DOI
2004-05
Neoadjuvant chemotherapy followed by radiotherapy in epidermoid carcinoma of anus
DOI
2004-06
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies
DOI
2004-06
Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients

Lee, June-Chul; Lee, Kyung-Mi; Kim, Dong-Wan; Heo, Dae Seog

Journal of Immunology, Vol.172 No.12, pp.7335-7340

DOI
2004-07
Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy
DOI
2004-11
A multi-center, late phase II clinical trial of Genexol (R) (paclitaxel) and cisplatin for patients with advanced gastric cancer
DOI
2004-11
Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma
DOI
2004-12
A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma
DOI
2005
Factors influencing preferences for place of terminal care and of death among cancer patients and their families in Korea
link
2005-01
Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa (R), ZD1839) in chemotherapy-resistant non-small cell lung cancer
DOI
2005-01
Paclitaxel/platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer
DOI
2005-04
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib
DOI
2005-07
Docetaxel+5-fluorouracil plus cisplatin 3-day combination chemotherapy as a first-line treatment in patient with unresectable gastric cancer
DOI
2005-07
Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer
DOI
2005-09
Management of gastric lymphoma with chemotherapy alone

Oh, D. Y.; Choi, I. S.; Kim, J. H.; Rhu, M. H.; Kim, T. Y.; Heo, Dae Seog; Bang, Y. J.; Kim, N. K.

Leukemia and Lymphoma, Vol.46 No.9, pp.1329-1335

DOI
2005-10
Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer
view fileDOI
2005-11
EuroQol and survival prediction in terminal cancer patients: a multicenter prospective study in hospice-palliative care units
link
2005-12
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I-E/IIE extranodal NK/T-cell lymphoma, nasal type
DOI
2005-12
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer
DOI
2006
Targeted therapy of DNA tumor virus-associated cancers using virus-activated transcription factors
link
2006-02
CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience
DOI
2006-02
Targeted therapy of DNA tumor virus-associated cancers using virus-activated transcription factors
link
2006-04
EuroQol and survival prediction in terminal cancer patients: a multicenter prospective study in hospice-palliative care unit
DOI
2006-06
Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer
DOI
2006-07
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma
DOI
2006-07
High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy
DOI
2006-08
Primary systemic anaplastic large cell lymphoma in a single Korean institution: Clinical characteristics and treatment outcome
view fileDOI
2006-08
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma
link
2006-09
Patient-reported assessment of quality care at end of life: Development and validation of Quality Care Questionnaire-End of Life (QCQ-EOL)
DOI
2006-11
Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients
DOI
2007-04
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
view fileDOI
2007-05
Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer
DOI
2007-06
Artificial nutrition and hydration in terminal cancer patients: the real and the ideal
DOI
2007-09
Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer
view file
2007-10
Palliative chemotherapy for pulmonary pleomorphic carcinoma
DOI
2007-11
Discrepancies in performance status scores as determined by cancer patients and oncologists: are they influenced by depression?

Jeon, Hong Jin; Shim, Eun-Jung; Shin, Yong-Wook; Oh, Do-Youn; Im, Seock-Ah; Heo, Dae Seog; Hahm, Bong-Jin

General Hospital Psychiatry, Vol.29 No.6, pp.555-561

DOI
2007-11
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
view fileDOI
2007-11
Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer
link
1 2 3 4 5

Seoul National University Library, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea TEL: 02-880-5567 Email: s-space@snu.ac.kr youtube

RSS 1.0 RSS 2.0 Atom

Hello

Browse

News About S-Space Seoul National University Library LOGIN